List of anticancer peptides Anti-cancer peptides (ACPs) represent a rapidly evolving class of therapeutic agents with a remarkable ability to specifically target and inhibit the growth and proliferation of cancer cells作者：N Ghadiri·2024·被引用次数：48—The peptide lycosin-1, produced from spider venom,successfully hinders the growth of cancer cellsin a laboratory setting and reduces tumor .... These short bioactive peptides, typically composed of 10 to 60 amino acids, are emerging as a significant addition to the pharmaceutical arsenal, offering a promising alternative to conventional cancer treatments.DCTPep, the data of cancer therapy peptides Their inherent selectivity for malignant cells, coupled with diverse mechanisms of action, positions them as a crucial area of research and development in the fight against cancer.
At their core, anti-cancer peptides are small molecules derived from amino acid sequences, distinguished from larger protein structures by their size. They are known for their potent ability to inhibit tumor cell proliferation, migration, and invasion. Unlike many traditional chemotherapies that affect both healthy and cancerous cells, ACPs are designed to selectively interact with cancer cells, minimizing damage to healthy tissues.Computational design of anti-cancer peptides tailored to target ... This targeted approach is a significant advantage, potentially leading to fewer side effects and improved patient outcomes.
The efficacy of anti-cancer peptides stems from their versatile mechanisms of action, which can be broadly categorized:
* Direct Cytotoxicity: Many ACPs exert their anti-cancer effects by directly inducing cancer cell death. This can occur through various pathways, including the disruption of cell membranes, leading to lysis, or by triggering programmed cell death (apoptosis).Review Current research status of anti-cancer peptides Some ACPs, particularly those derived from antimicrobial peptides, function as cytolytic agents capable of creating pores in cancer cell membranes.Anti-cancer peptide-based therapeutic strategies in solid ...
* Inhibition of Tumor Growth and Metastasis: Beyond direct killing, ACPs can interfere with critical processes that drive cancer progression. They can inhibit tumor cell proliferation, effectively halting the uncontrolled division of malignant cells.作者：M Xie·2020·被引用次数：288—Anti-cancer peptides (ACPs) area series of short peptides composed of 10–60 amino acidsthat can inhibit tumour cell proliferation or migration ... Furthermore, some ACPs are known to impede cancer cell migration and the formation of new blood vessels (angiogenesis) that tumors rely on for growth, thereby preventing metastasis.
* Immunomodulation: A growing area of research highlights the immunomodulatory capabilities of ACPs. These peptides can influence the immune system's response to cancer, either by directly stimulating immune cells to attack tumor cells or by modulating inflammatory responses that can otherwise support tumor growth.Anti-cancer peptides: classification, mechanism of action ... Some ACPs can act as vaccine neoantigens or adjuvants, enhancing the body's ability to recognize and combat cancer.
* Targeted Delivery: Peptides can also be engineered or utilized as delivery systems for other anti-cancer agents, ensuring their precise delivery to tumor sites. This targeted delivery approach can enhance the efficacy of existing treatments while reducing systemic toxicityVenom-based peptide therapy: insights into anti-cancer ....
Anti-cancer peptides can be derived from a variety of natural and synthetic sources and are classified based on their origin, structure, and function.
* Natural Sources: Many promising ACPs have been identified from natural sources, including animal venoms (e.g., spider venom peptides like lycosin-1), antimicrobial peptides (AMPs) produced by various organisms, and even certain plant-derived compounds. These natural peptides have evolved over time to possess potent bioactivity, making them valuable starting points for therapeutic development.Which Peptides May Be Used While Fighting Cancer?
* Synthetic and Engineered Peptides: Advances in computational design and synthetic biology have enabled the creation of novel ACPs tailored to specific cancer targets. These engineered peptides can be designed to optimize their binding affinity, stability, and therapeutic efficacy.Anti-cancer peptide-based therapeutic strategies in solid ...
Researchers are also exploring different subtypes of ACPs based on their physicochemical properties and amino acid composition, aiming to better understand their specific modes of action and improve their therapeutic potential.Anti-cancer peptides: classification, mechanism of action ...
The exploration of anti-cancer peptides is driven by their significant potential to overcome challenges associated with current cancer therapies, such as treatment resistance and tumor heterogeneity. Their small size allows for better tissue penetration compared to larger molecules. Furthermore, the ongoing research into peptide-based anticancer therapeutics, including hormone analogs like octreotide, leuprolide, and goserelin, underscores their established role in certain cancer treatments.
The future of anti-cancer peptides appears bright, with ongoing efforts focused on:
* Enhancing Selectivity and Potency: Developing more sophisticated ACPs that exhibit even greater specificity for cancer cells and higher potency against a broader range of tumors.
* Improving Delivery and Stability: Addressing challenges related to peptide stability in the body and developing effective delivery systems to ensure optimal therapeutic concentrations at the tumor site.
* Combination Therapies: Investigating the synergistic effects of ACPs when used in combination with existing chemotherapy, immunotherapy, or radiation therapy.
* Personalized Medicine: Leveraging the targeted nature of peptides for personalized cancer treatment strategies, tailoring therapies based on the specific genetic makeup of a patient's tumor.
While still a dynamic field of research, anti-cancer peptides offer a compelling vision for the future of cancer treatment, promising more targeted, effective, and less toxic therapeutic options作者：SMP Vadevoo·2023·被引用次数：183—In the current market,peptide-based anticancer therapeuticsinclude hormone analogs such as octreotide, leuprolide, and goserelin.. Continued investigation into their mechanisms, sources, and applications is crucial to fully harness their potential in combating this complex disease.
Join the newsletter to receive news, updates, new products and freebies in your inbox.